Integral Health Asset Management’s Heron Therapeutics HRTX Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2022
Q4 | – | Sell |
-700,000
| Closed | -$2.95M | – | 75 |
|
2022
Q3 | $2.95M | Sell |
700,000
-300,000
| -30% | -$1.27M | 0.57% | 55 |
|
2022
Q2 | $2.79M | Hold |
1,000,000
| – | – | 0.57% | 52 |
|
2022
Q1 | $5.72M | Buy |
1,000,000
+250,000
| +33% | +$1.43M | 1.49% | 27 |
|
2021
Q4 | $6.85M | Buy |
750,000
+340,000
| +83% | +$3.1M | 1.89% | 20 |
|
2021
Q3 | $4.38M | Buy |
410,000
+310,000
| +310% | +$3.31M | 1.26% | 31 |
|
2021
Q2 | $1.55M | Buy |
+100,000
| New | +$1.55M | 0.43% | 59 |
|